| scholarly article | Q13442814 |
| P2093 | author name string | Christopher A Hunter | |
| Phillip Scott | |||
| Mark R Ackermann | |||
| Douglas E Jones | |||
| Ulrike Wille | |||
| P2860 | cites work | Interleukin-10 | Q28263225 |
| IL-10 inhibits cytokine production by activated macrophages | Q29619453 | ||
| Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. | Q33602903 | ||
| Analysis of the immune responses of mice to infection with Leishmania braziliensis | Q33750694 | ||
| Cytokine patterns in the pathogenesis of human leishmaniasis | Q33895266 | ||
| Proteophosphoglycan, a major secreted product of intracellular Leishmania mexicana amastigotes, is a poor B-cell antigen and does not elicit a specific conventional CD4+ T-cell response | Q34002187 | ||
| A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells | Q34492059 | ||
| Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression | Q34504988 | ||
| Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii | Q35546330 | ||
| Regulation of immunity to parasites by T cells and T cell-derived cytokines | Q36135203 | ||
| Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells | Q36362214 | ||
| Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase | Q36366480 | ||
| High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. | Q36367196 | ||
| Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis | Q36368360 | ||
| Altered immune responses in interleukin 10 transgenic mice | Q36377330 | ||
| Genetic analysis of Leishmania mexicana infection in mice: single gene (Scl-2) controlled predisposition to cutaneous lesion development | Q39402084 | ||
| T helper cell differentiation in immune response | Q40404872 | ||
| Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages | Q40986436 | ||
| Cutaneous leishmaniasis due to Leishmania (Leishmania) amazonensis in Amazonian Brazil, and the significance of a negative Montenegro skin-test in human infections | Q41149686 | ||
| IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells | Q41684085 | ||
| H-2M molecules, like MHC class II molecules, are targeted to parasitophorous vacuoles of Leishmania-infected macrophages and internalized by amastigotes of L. amazonensis and L. mexicana. | Q42605000 | ||
| IL-4-deficient Balb/c mice resist infection with Leishmania major | Q42943751 | ||
| Visualizing the generation of memory CD4 T cells in the whole body | Q43695394 | ||
| Down-regulation of Th1 type of response in early human American cutaneous leishmaniasis | Q45221986 | ||
| IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression | Q50335918 | ||
| IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. | Q50767944 | ||
| Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. | Q52519428 | ||
| Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection. | Q52525664 | ||
| Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis. | Q52532776 | ||
| Inbred mice as model hosts for cutaneous leishmaniasis. I. Resistance and susceptibility to infection with Leishmania braziliensis, L. mexicana, and L. aethiopica. | Q54479673 | ||
| IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease | Q57339957 | ||
| In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha | Q57339973 | ||
| IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi | Q58843169 | ||
| Enhancement of Leishmania amazonensis infection in BCG non-responder mice by BCG-antigen specific vaccine | Q67511928 | ||
| Susceptibility to Leishmania major infection in interleukin-4-deficient mice | Q70960225 | ||
| Late metastatic Leishmaniasis in the mouse. A model for mucocutaneous disease | Q71700050 | ||
| Variation of cytokine patterns related to therapeutic response in diffuse cutaneous leishmaniasis | Q71810309 | ||
| Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells | Q71825225 | ||
| IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis | Q72191697 | ||
| Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production | Q72216265 | ||
| The role of IL-10 in promoting disease progression in leishmaniasis | Q73365816 | ||
| IL-4 and IL-10 modulation of CD40-mediated signaling of monocyte IL-1beta synthesis and rescue from apoptosis | Q73500995 | ||
| CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10 | Q73509865 | ||
| IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii | Q73755946 | ||
| IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis | Q73869153 | ||
| Secreted proteophosphoglycan of Leishmania mexicana amastigotes activates complement by triggering the mannan binding lectin pathway | Q73878080 | ||
| IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection | Q73910768 | ||
| IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains | Q77404910 | ||
| Experimental Leishmania major infection in mice: role of IL-10 | Q77731135 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | interleukins | Q194908 |
| Leishmania amazonensis | Q30314626 | ||
| P304 | page(s) | 2151-2158 | |
| P577 | publication date | 2002-04-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection. | |
| P478 | volume | 70 |
| Q36094676 | A Proteomic Investigation of Hepatic Resistance to Ascaris in a Murine Model |
| Q34155496 | A comparison of two distinct murine macrophage gene expression profiles in response to Leishmania amazonensis infection. |
| Q37164233 | Altered dendritic cell phenotype in response to Leishmania amazonensis amastigote infection is mediated by MAP kinase, ERK |
| Q34142338 | An in vitro model of antibody-enhanced killing of the intracellular parasite Leishmania amazonensis |
| Q33859617 | Animal models for the study of leishmaniasis immunology. |
| Q34491852 | Antigen-responsive CD4+ T cells from C3H mice chronically infected with Leishmania amazonensis are impaired in the transition to an effector phenotype |
| Q36446351 | CD4+ Th1 cells induced by dendritic cell-based immunotherapy in mice chronically infected with Leishmania amazonensis do not promote healing |
| Q35220391 | CXCL10/gamma interferon-inducible protein 10-mediated protection against Leishmania amazonensis infection in mice |
| Q41059758 | Characterization of the B cell response to Leishmania infection after anti-CD20 B cell depletion. |
| Q26752521 | Cutaneous Leishmaniasis Vaccination: A Matter of Quality |
| Q33839048 | Cutaneous Manifestations of Human and Murine Leishmaniasis |
| Q33548768 | Delineation of diverse macrophage activation programs in response to intracellular parasites and cytokines |
| Q92289014 | Differential immune response modulation in early Leishmania amazonensis infection of BALB/c and C57BL/6 macrophages based on transcriptome profiles |
| Q34347500 | Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? |
| Q36973139 | Down-regulation of dendritic cell signaling pathways by Leishmania amazonensis amastigotes |
| Q43874096 | Dynamic identification of H2 epitopes from Leishmania (Leishmania) amazonensis cysteine proteinase B with potential immune activity during murine infection. |
| Q40103940 | EVALUATION OF EXPERIMENTAL INFECTION WITH L. (L.) AMAZONENSIS IN X-LINKED IMMUNODEFICIENT MICE. |
| Q36422047 | Effects of CXCL10 on dendritic cell and CD4+ T-cell functions during Leishmania amazonensis infection |
| Q40513787 | Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl/6 mice |
| Q36421562 | FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions |
| Q36382893 | IFN-γ-Dependent Recruitment of CD4(+) T Cells and Macrophages Contributes to Pathogenesis During Leishmania amazonensis Infection |
| Q36001280 | IL-10 is critical for Th2 responses in a murine model of allergic dermatitis |
| Q35085800 | IL-2 limits IL-12 enhanced lymphocyte proliferation during Leishmania amazonensis infection. |
| Q36593757 | Immune privilege in sites of chronic infection: Leishmania and regulatory T cells |
| Q41730142 | Immune response in susceptible BALB/c mice immunized with DNA encoding Lipophosphoglycan 3 of Leishmania infantum |
| Q35106404 | Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection. |
| Q33627078 | Immunologic indicators of clinical progression during canine Leishmania infantum infection |
| Q37298910 | Immunological characteristics of experimental murine infection with Leishmania (Leishmania) amazonensis. |
| Q36778997 | Impact of reactive oxygen species (ROS) on the control of parasite loads and inflammation in Leishmania amazonensis infection |
| Q35165095 | Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis |
| Q36399907 | Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells |
| Q33769299 | Interleukin 10- and Fcgamma receptor-deficient mice resolve Leishmania mexicana lesions |
| Q57552138 | Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice |
| Q36446275 | Intranasal vaccination against cutaneous leishmaniasis with a particulated leishmanial antigen or DNA encoding LACK. |
| Q43123081 | Leishmania (Leishmania) amazonensis infection in mice treated with FTY720. |
| Q40101180 | Leishmania amazonensis-Induced cAMP Triggered by Adenosine A2B Receptor Is Important to Inhibit Dendritic Cell Activation and Evade Immune Response in Infected Mice. |
| Q36593911 | Leishmania pifanoi proteoglycolipid complex P8 induces macrophage cytokine production through Toll-like receptor 4. |
| Q35055651 | Leishmania promotes its own virulence by inducing expression of the host immune inhibitory ligand CD200 |
| Q96685952 | Leishmania-Specific Promiscuous Membrane Protein Tubulin Folding Cofactor D Divulges Th1/Th2 Polarization in the Host via ERK-1/2 and p38 MAPK Signaling Cascade |
| Q42859581 | Low and high-dose intradermal infection with Leishmania majorand Leishmania amazonensis in C57BL/6 mice |
| Q37118101 | Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example. |
| Q40171180 | Mining the Proteome of Leishmania donovani for the Development of Novel MHC Class I Restricted Epitope for the Control of Visceral Leishmaniasis. |
| Q37091427 | Modulation of dendritic cell function by Leishmania parasites |
| Q83358553 | Multifunctional CD4⁺ T cells in patients with American cutaneous leishmaniasis |
| Q46466695 | Mycobacterium hsp65 DNA entrapped into TDM-loaded PLGA microspheres induces protection in mice against Leishmania (Leishmania) major infection. |
| Q35015652 | Neutrophils have a protective role during early stages of Leishmania amazonensis infection in BALB/c mice. |
| Q42801015 | Pentalinon andrieuxii root extract is effective in the topical treatment of cutaneous leishmaniasis caused by Leishmania mexicana. |
| Q35951825 | Promotion of a functional B cell germinal center response after Leishmania species co-infection is associated with lesion resolution |
| Q38015852 | Protective immunity and vaccination against cutaneous leishmaniasis. |
| Q28075695 | Purinergic signaling and infection by Leishmania: A new approach to evasion of the immune response |
| Q35884239 | Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice |
| Q36576052 | Sand fly saliva enhances Leishmania amazonensis infection by modulating interleukin-10 production |
| Q42020093 | Subversion of Immunity by Leishmania amazonensis Parasites: Possible Role of Phosphatidylserine as a Main Regulator. |
| Q33669426 | Suppression of LPS-induced inflammatory responses in macrophages infected with Leishmania |
| Q39030620 | Targeted extracellular signal-regulated kinase activation mediated by Leishmania amazonensis requires MP1 scaffold |
| Q44997081 | Th1 and Th2 immunological profile induced by cysteine proteinase in murine leishmaniasis |
| Q42402246 | The Effect of Aqueous Garlic Extract on Interleukin-12 and 10 Levels in Leishmania major (MRHO/IR/75/ER) Infected Macrophages. |
| Q79074379 | The Role of Interleukin-10 in Susceptibility of BALB/c Mice to Infection with Leishmania mexicana and Leishmania amazonensis |
| Q33988743 | The magnitude of CD4(+) T-cell activation rather than TCR diversity determines the outcome of Leishmania infection in mice |
| Q33885793 | Transplacental transmission of Leishmania infantum as a means for continued disease incidence in North America. |
Search more.